Insulin Delivery Device Market to Witness the Highest Growth Globally in Coming Years | P&S Intelligence

Diabetes is a fairly common, but menacing disorder, affecting 422 million in 2014, as per the World Health Organization (WHO). Its complications include kidney diseases, cardiovascular diseases, stroke, and eye disorders. Along with aging, which is its most common cause, improper diet, lack of exercise, and other poor lifestyle choices can also cause diabetes. Though there is no treatment for the condition, there is one proven way to control it — insulin intake. This is why the insulin delivery device market, which valued $9.9 billion in 2015, is projected to expand to $15.5 billion by 2022, at a CAGR of 6.6% during 2016¬–2022.

Request for a sample of this research report:
https://www.psmarketresearch.com/market-analysis/insulin-delivery-devices/report-sample

The drug can be given by pens, pumps, and syringes, among which pens were the most popular across the world during 2012–2015. The major advantages that result in a high preference for pens include accurate dosage and less injection pain. Additionally, due to their ease of use, patients can administer the dose themselves, without depending on a caregiver. Further, as there is no need pull the plunger, unlike syringes, the chances of an air bubble getting sucked in and entering the bloodstream are minimal.

Explore Full Report at:
https://www.psmarketresearch.com/market-analysis/insulin-delivery-devices

Another important cause of the disorder, particularly type 2 diabetes mellitus, is obesity, which is therefore another major reason behind the growing usage of insulin and delivery devices. As per WHO’s 2018 data, the prevalence of obesity has become three times as that in 1975. Of the 1.9 billion people over the age of 18 years, who were overweight in 2016, 650 million were obese. With more people becoming obese, the number of diabetes patients would also increase, thereby resulting in the growing requirement for insulin delivery devices.

During the historical period, the sales of insulin delivery devices were highest in North America, owing to its high number of diabetics. As per the International Diabetes Federation, the number of people battling the disorder in North America and the Caribbean is projected to reach 60.5 million in 2035, from 44.3 million in 2015. During the forecast period, the insulin delivery device market growth in Asia-Pacific (APAC) would be the fastest. Governments in the region are not only running awareness programs, but also investing in healthcare infrastructure improvement and make medical services available in rural areas.

Therefore, with the growing population of the elderly and the obese, diabetes would claim more victims, which would further push the demand for insulin delivery devices in the near future.

About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.